Haptoglobin and sickle cell polymorphisms and risk of active trachoma in gambian children

PLoS ONE

Volumn 5, Issue 6, 2010, Pages

  Savy, Mathilde ^a   Hennig, Branwen J ^a   Doherty, Conor P ^b   Fulford, Anthony J ^a   Bailey, Robin ^b,c   Holland, Martin J ^b,c   Sirugo, Giorgio ^b,d   Rockett, Kirk A ^e   Kwiatkowski, Dominic P ^e,f   Prentice, AndrewM ^a   Cox, Sharon E ^a  

^a MEDICAL RESEARCH COUNCIL   (United Kingdom)

^b MEDICAL RESEARCH COUNCIL LABORATORIES   (Gambia)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^d FATEBENEFRATELLI HOSPITAL   (Italy)

^e UNIVERSITY OF OXFORD   (United Kingdom)

^f WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HAPTOGLOBIN; HEMOGLOBIN S; PRIMER DNA;

ARTICLE; CHILD; CHLAMYDIA TRACHOMATIS; CONTROLLED STUDY; FEMALE; GAMBIA; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PREVALENCE; PROMOTER REGION; RURAL POPULATION; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; TRACHOMA; CROSS-SECTIONAL STUDY; GENETIC PREDISPOSITION; GENETICS; HAPLOTYPE; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; RISK FACTOR; SICKLE CELL ANEMIA;

CHLAMYDIA TRACHOMATIS;

ANEMIA, SICKLE CELL; BASE SEQUENCE; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; DNA PRIMERS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HAPTOGLOBINS; HUMANS; INFANT; MALE; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; RURAL POPULATION; TRACHOMA;

EID: 77956222396     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0011075     Document Type: Article

References (67)

1. Resnikoff S, Pascolini D, Etya'ale D, Kocur I, Pararajasegaram R, et al. (2004) Global data on visual impairment in the year 2002. Bull World Health Organ 82: 844-851.
2. Mabey DC, Solomon AW, Foster A (2003) Trachoma. Lancet 362: 223-229.
3. Abdou A, Nassirou B, Kadri B, Moussa F, Munoz BE, et al. (2007) Prevalence and risk factors for trachoma and ocular Chlamydia trachomatis infection in Niger. Br J Ophthalmol 91: 13-17.
4. Courtright P, West SK (2004) Contribution of sex-linked biology and gender roles to disparities with trachoma. Emerg Infect Dis 10: 2012-2016.
5. Stephens RS (2003) The cellular paradigm of chlamydial pathogenesis. Trends Microbiol 11: 44-51.
6. Ward M, Bailey R, Lesley A, Kajbaf M, Robertson J, et al. (1990) Persisting inapparent chlamydial infection in a trachoma endemic community in The Gambia. Scand J Infect Dis Suppl 69: 137-148.
7. West SK, Munoz B, Mkocha H, Hsieh YH, Lynch MC (2001) Progression of active trachoma to scarring in a cohort of Tanzanian children. Ophthalmic Epidemiol 8: 137-144.
8. International Trachoma Initiative (2006) Annual report 2006. New York, USA: International Trachoma Initiative. 24 p.
9. Clementi M, Di Gianantonio E (2006) Genetic susceptibility to infectious diseases. Reprod Toxicol 21: 345-349.
10. Hill AV (2006) Aspects of genetic susceptibility to human infectious diseases. Annu Rev Genet 40: 469-486.
11. Gambhir M, Basanez MG, Turner F, Kumaresan J, Grassly NC (2007) Trachoma: transmission, infection, and control. Lancet Infect Dis 7: 420-427.
12. Natividad A, Hull J, Luoni G, Holland M, Rockett K, et al. (2009) Innate immunity in ocular Chlamydia trachomatis infection: contribution of IL8 and CSF2 gene variants to risk of trachomatous scarring in Gambians. BMC Med Genet 10: 138.
13. Atik B, Skwor TA, Kandel RP, Sharma B, Adhikari HK, et al. (2008) Identification of novel single nucleotide polymorphisms in inflammatory genes as risk factors associated with trachomatous trichiasis. PLoS One 3: e3600.
14. Conway DJ, Holland MJ, Bailey RL, Campbell AE, Mahdi OS, et al. (1997) Scarring trachoma is associated with polymorphism in the tumor necrosis factor alpha (TNF-alpha) gene promoter and with elevated TNF-alpha levels in tear fluid. Infect Immun 65: 1003-1006.
15. Natividad A, Hanchard N, Holland MJ, Mahdi OS, Diakite M, et al. (2007) Genetic variation at the TNF locus and the risk of severe sequelae of ocular Chlamydia trachomatis infection in Gambians. Genes Immun 8: 288-295.
16. Mozzato-Chamay N, Mahdi OS, Jallow O, Mabey DC, Bailey RL, et al. (2000) Polymorphisms in candidate genes and risk of scarring trachoma in a Chlamydia trachomatis-endemic population. J Infect Dis 182: 1545-1548.
17. Natividad A, Wilson J, Koch O, Holland MJ, Rockett K, et al. (2005) Risk of trachomatous scarring and trichiasis in Gambians varies with SNP haplotypes at the interferon-gamma and interleukin-10 loci. Genes Immun 6: 332-340.
18. Conway DJ, Holland MJ, Campbell AE, Bailey RL, Krausa P, et al. (1996) HLA class I and II polymorphisms and trachomatous scarring in a Chlamydia trachomatis-endemic population. J Infect Dis 174: 643-646.
19. Natividad A, Holland MJ, Rockett KA, Forton J, Faal N, et al. (2008) Susceptibility to sequelae of human ocular chlamydial infection associated with allelic variation in IL10 cis-regulation. Hum Mol Genet 17: 323-329.
20. Al-Younes HM, Rudel T, Brinkmann V, Szczepek AJ, Meyer TF (2001) Low iron availability modulates the course of Chlamydia pneumoniae infection. Cell Microbiol 3: 427-437.
21. Freidank HM, Billing H, Wiedmann-Al-Ahmad M (2001) Influence of iron restriction on Chlamydia pneumoniae and C. trachomatis. J Med Microbiol 50: 223-227.
22. Raulston JE (1997) Response of Chlamydia trachomatis serovar E to iron restriction in vitro and evidence for iron-regulated chlamydial proteins. Infect Immun 65: 4539-4547.
23. LaRue RW, Dill BD, Giles DK, Whittimore JD, Raulston JE (2007) Chlamydial Hsp60-2 is iron responsive in Chlamydia trachomatis serovar E-infected human endometrial epithelial cells in vitro. Infect Immun 75: 2374-2380.
24. Slepenkin A, Enquist PA, Hagglund U, de la Maza LM, Elofsson M, et al. (2007) Reversal of the antichlamydial activity of putative type III secretion inhibitors by iron. Infect Immun 75: 3478-3489.
25. van Ooij C, Apodaca G, Engel J (1997) Characterization of the Chlamydia trachomatis vacuole and its interaction with the host endocytic pathway in HeLa cells. Infect Immun 65: 758-766.
26. Teye K, Quaye IK, Koda Y, Soejima M, Tsuneoka M, et al. (2003) A-61C and C-101G Hp gene promoter polymorphisms are, respectively, associated with ahaptoglobinaemia and hypohaptoglobinaemia in Ghana. Clin Genet 64: 439-443.
27. Grant DJ, Maeda N (1993) A base substitution in the promoter associated with the human haptoglobin 2-1 modified phenotype decreases transcriptional activity and responsiveness to interleukin-6 in human hepatoma cells. Am J Hum Genet 52: 974-980.
28. Kristiansen M, Graversen JH, Jacobsen C, Sonne O, Hoffman HJ, et al. (2001) Identification of the haemoglobin scavenger receptor. Nature 409: 198-201.
29. Moestrup SK, Moller HJ (2004) CD163: a regulated hemoglobin scavenger receptor with a role in the anti-inflammatory response. Ann Med 36: 347-354.
30. Okazaki T, Nagai T (1997) Difference in hemoglobin-binding ability of polymers among haptoglobin phenotypes. Clin Chem 43: 2012-2013.
31. Delanghe JR, Langlois MR, De Buyzere ML, Torck MA (2007) Vitamin C deficiency and scurvy are not only a dietary problem but are codetermined by the haptoglobin polymorphism. Clin Chem 53: 1397-1400.
32. Melamed-Frank M, Lache O, Enav BI, Szafranek T, Levy NS, et al. (2001) Structure-function analysis of the antioxidant properties of haptoglobin. Blood 98: 3693-3698.
33. Atkinson SH, Rockett K, Sirugo G, Bejon PA, Fulford A, et al. (2006) Seasonal childhood anaemia in West Africa is associated with the haptoglobin 2-2 genotype. PLoS Med 3: e172.
34. Cox SE, Doherty CP, Atkinson SH, Nweneka CV, Fulford A, et al. (2008) Haptoglobin Genotype, Anaemia and Malaria in Gambian Children. Trop Med Int Health.
35. Guetta J, Strauss M, Levy NS, Fahoum L, Levy AP (2006) Haptoglobin genotype modulates the balance of Th1/Th2 cytokines produced by macrophages exposed to free hemoglobin. Atherosclerosis.
36. Asleh R, Marsh S, Shilkrut M, Binah O, Guetta J, et al. (2003) Genetically determined heterogeneity in hemoglobin scavenging and susceptibility to diabetic cardiovascular disease. Circ Res 92: 1193-1200.
37. Mustafa S, Vukovich T, Prikoszovich T, Winzer C, Schneider B, et al. (2004) Haptoglobin phenotype and gestational diabetes. Diabetes Care 27: 2103-2107.
38. Quaye IK, Ababio G, Amoah AG (2006) Haptoglobin 2-2 phenotype is a risk factor for type 2 diabetes in Ghana. J Atheroscler Thromb 13: 90-94.
39. Delanghe JR, Langlois MR, Boelaert JR, Van Acker J, Van Wanzeele F, et al. (1998) Haptoglobin polymorphism, iron metabolism and mortality in HIV infection. Aids 12: 1027-1032.
40. Friis H, Gomo E, Nyazema N, Ndhlovu P, Krarup H, et al. (2003) Iron, haptoglobin phenotype, and HIV-1 viral load: a cross-sectional study among pregnant Zimbabwean women. J Acquir Immune Defic Syndr 33: 74-81.
41. Quaye IK, Ekuban FA, Brandful JA, Gyan BA, Akanmori BD, et al. (2000) Haptoglobin phenotypes in HIV-1-seropositive patients in Ghana: decreased risk for Hp0 individuals. Hum Hered 50: 382-383.
42. Elagib AA, Kider AO, Akerstrom B, Elbashir MI (1998) Association of the haptoglobin phenotype (1-1) with falciparum malaria in Sudan. Trans R Soc Trop Med Hyg 92: 309-311.
43. Minang JT, Gyan BA, Anchang JK, Troye-Blomberg M, Perlmann H, et al. (2004) Haptoglobin phenotypes and malaria infection in pregnant women at delivery in western Cameroon. Acta Trop 90: 107-114.
44. Singh IP, Walter H, Bhasin MK, Bhardwaj V, Sudhakar K (1986) Genetic markers and malaria. Observations in Gujarat, India. Hum Hered 36: 31-36.
45. Atkinson SH, Mwangi TW, Uyoga SM, Ogada E, Macharia AW, et al. (2007) The haptoglobin 2-2 genotype is associated with a reduced incidence of Plasmodium falciparum malaria in children on the coast of Kenya. Clin Infect Dis 44: 802-809.
46. Cox SE, Doherty C, Atkinson SH, Nweneka CV, Fulford AJ, et al. (2007) Haplotype association between haptoglobin (Hp2) and Hp promoter SNP (A- 61C) may explain previous controversy of haptoglobin and malaria protection. PLoS ONE 2: e362.
47. Aidoo M, Terlouw DJ, Kolczak MS, McElroy PD, ter Kuile FO, et al. (2002) Protective effects of the sickle cell gene against malaria morbidity and mortality. Lancet 359: 1311-1312.
48. Cabrera G, Cot M, Migot-Nabias F, Kremsner PG, Deloron P, et al. (2005) The sickle cell trait is associated with enhanced immunoglobulin G antibody responses to Plasmodium falciparum variant surface antigens. J Infect Dis 191: 1631-1638.
49. Williams TN, Mwangi TW, Roberts DJ, Alexander ND, Weatherall DJ, et al. (2005) An immune basis for malaria protection by the sickle cell trait. PLoS Med 2: e128.
50. Williams TN, Mwangi TW, Wambua S, Alexander ND, Kortok M, et al. (2005) Sickle cell trait and the risk of Plasmodium falciparum malaria and other childhood diseases. J Infect Dis 192: 178-186.
51. Jallow M, Teo YY, Small KS, Rockett KA, Deloukas P, et al. (2009) Genomewide and fine-resolution association analysis of malaria in West Africa. Nat Genet.
52. Allen SJ, O'Donnell A, Alexander ND, Alpers MP, Peto TE, et al. (1997) alpha+-Thalassemia protects children against disease caused by other infections as well as malaria. Proc Natl Acad Sci U S A 94: 14736-14741.
53. Thylefors B, Dawson CR, Jones BR, West SK, Taylor HR (1987) A simple system for the assessment of trachoma and its complications. Bull World Health Organ 65: 477-483.
54. Harding-Esch EM, Edwards T, Sillah A, Sarr I, Roberts CH, et al. (2009) Active trachoma and ocular Chlamydia trachomatis infection in two Gambian regions: on course for elimination by 2020? PLoS Negl Trop Dis 3: e573.
55. Miller SA, Dykes DD, Polesky HF (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16: 1215.
56. Koch W, Latz W, Eichinger M, Roguin A, Levy AP, et al. (2002) Genotyping of the common haptoglobin Hp 1/2 polymorphism based on PCR. Clin Chem 48: 1377-1382.
57. Koch W, Latz W, Eichinger M, Gschwendner C, Teige B, et al. (2003) Haptoglobin gene subtyping by restriction enzyme analysis. Clin Chem 49: 1937-1940.
58. Clayton D SNPHAP: a program for estimating frequencies of large haplotypes of SNPs (Version 1.0). 1.0 ed. Cambridge: Institute for Medical Research).
59. Sirugo G, Schim van der Loeff M, Sam O, Nyan O, Pinder M, et al. (2004) A national DNA bank in The Gambia, West Africa, and genomic research in developing countries. Nat Genet 36: 785-786.
60. Wieringa FT, Berger J, Dijkhuizen MA, Hidayat A, Ninh NX, et al. (2007) Sex differences in prevalence of anaemia and iron deficiency in infancy in a large multi-country trial in South-East Asia. Br J Nutr 98: 1070-1076.
61. Arredouani M, Matthijs P, Van Hoeyveld E, Kasran A, Baumann H, et al. (2003) Haptoglobin directly affects T cells and suppresses T helper cell type 2 cytokine release. Immunology 108: 144-151.
62. Quaye IK (2008) Haptoglobin, inflammation and disease. Trans R Soc Trop Med Hyg 102: 735-742.
63. Langlois M, Delanghe J, Philippe J, Ouyang J, Bernard D, et al. (1997) Distribution of lymphocyte subsets in bone marrow and peripheral blood is associated with haptoglobin type. Binding of haptoglobin to the B-cell lectin CD22. Eur J Clin Chem Clin Biochem 35: 199-205.
64. Fish EN (2008) The X-files in immunity: sex-based differences predispose immune responses. Nat Rev Immunol 8: 737-744.
65. Klein SL (2004) Hormonal and immunological mechanisms mediating sex differences in parasite infection. Parasite Immunol 26: 247-264.
66. Langlois MR, Martin ME, Boelaert JR, Beaumont C, Taes YE, et al. (2000) The haptoglobin 2-2 phenotype affects serum markers of iron status in healthy males. Clin Chem 46: 1619-1625.
67. Kasvosve I, Gordeuk VR, Delanghe JR, Gomo ZA, Gangaidzo IT, et al. (2002) Iron status in black persons is not influenced by haptoglobin polymorphism. Clin Chem Lab Med 40: 810-813.